• G. Prasanna
• G. Sharathchandra
• C. Hyma
• P. Pallavi
• K. SaiTejeswini, Y. Chandravadhana

Bone cancer is the term for several different cancers that develop in the bones. When cancer cells grow in a bone, it can harm normal bone tissue. The type of cell and tissue where cancer begins determines the type of bone cancer. Cancers that form in the bone itself are called primary bone cancers. Osteosarcoma mainly occurs in young people between the ages of 10 and 30, rare in middle aged people and very less in geriatrics. Causes and symptoms of bone cancer, mechanism and management of bone cancer, cytogenic molecular genetic alterations in bone tumour, genetic of aspects of bone tumour, bones and joint cancer, pathology and genetics, approach to the diagnosis of bone and soft tissue tumours clinical radiologic and classification aspects, epidemiology of primary bone tumours and economical aspects of bone metastasis. Bone tumours are extremely rare, with over 60 different subtypes being recognised. Their scarcity likely contributed to the logistics difficulties in research for improved diagnosis and treatment. Treatment includes surgery chemotherapy, surgery and radiotherapy.

Bone Cancer, osteosarcoma, Metastasis, chemotherapy, Radiotherapy

"PHARMACOLOGY OF BONE CANCER", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 12, page no.g570-g588, December-2023, Available :http://www.jetir.org/papers/JETIR2312666.pdf

"PHARMACOLOGY OF BONE CANCER", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 12, page no. ppg570-g588, December-2023, Available at : http://www.jetir.org/papers/JETIR2312666.pdf